Similar articles for PMID: 23306012

Year	Number of Results
1998	1
2004	1
2006	4
2007	4
2008	3
2009	5
2010	4
2011	11
2012	13
2013	11
2014	8
2015	12
2016	17
2017	14
2018	9
2019	6
2020	3
2021	2
2022	2
2023	1
2024	0

1

T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma.

King AD, Keung CK, Yu KH, Mo FK, Bhatia KS, Yeung DK, Tse GM, Vlantis AC, Ahuja AT. King AD, et al. AJNR Am J Neuroradiol. 2013 Jun-Jul;34(6):1237-41. doi: 10.3174/ajnr.A3378. Epub 2013 Jan 10. AJNR Am J Neuroradiol. 2013. PMID: 23306012 Free PMC article.

2

Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.

Yu Y, Mabray M, Silveira W, Shen PY, Ryan WR, Uzelac A, Yom SS. Yu Y, et al. Head Neck. 2017 Mar;39(3):432-438. doi: 10.1002/hed.24606. Epub 2016 Oct 11. Head Neck. 2017. PMID: 27726241

3

Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma.

Vandecaveye V, Dirix P, De Keyzer F, Op de Beeck K, Vander Poorten V, Hauben E, Lambrecht M, Nuyts S, Hermans R. Vandecaveye V, et al. Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1098-107. doi: 10.1016/j.ijrobp.2011.02.044. Epub 2011 Apr 20. Int J Radiat Oncol Biol Phys. 2012. PMID: 21514067

4

Detection of residual head and neck squamous cell carcinoma after (chemo)radiotherapy: a pilot study assessing the value of diffusion-weighted magnetic resonance imaging as an adjunct to PET-CT using ¹⁸F-FDG.

Noij DP, Jagesar VA, de Graaf P, de Jong MC, Hoekstra OS, de Bree R, Castelijns JA. Noij DP, et al. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Sep;124(3):296-305.e2. doi: 10.1016/j.oooo.2017.04.011. Epub 2017 May 3. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017. PMID: 28539202

5

Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response.

King AD, Chow KK, Yu KH, Mo FK, Yeung DK, Yuan J, Bhatia KS, Vlantis AC, Ahuja AT. King AD, et al. Radiology. 2013 Feb;266(2):531-8. doi: 10.1148/radiol.12120167. Epub 2012 Nov 14. Radiology. 2013. PMID: 23151830

6

Differentiation of recurrent tumor and posttreatment changes in head and neck squamous cell carcinoma: application of high b-value diffusion-weighted imaging.

Hwang I, Choi SH, Kim YJ, Kim KG, Lee AL, Yun TJ, Kim JH, Sohn CH. Hwang I, et al. AJNR Am J Neuroradiol. 2013 Dec;34(12):2343-8. doi: 10.3174/ajnr.A3603. Epub 2013 Jun 27. AJNR Am J Neuroradiol. 2013. PMID: 23811978 Free PMC article.

7

Use of Diffusion-Weighted Imaging and ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography Combined With Computed Tomography in the Response Assessment for (Chemo)radiotherapy in Head and Neck Squamous Cell Carcinoma.

Noij DP, Martens RM, Koopman T, Hoekstra OS, Comans EFI, Zwezerijnen B, de Bree R, de Graaf P, Castelijns JA. Noij DP, et al. Clin Oncol (R Coll Radiol). 2018 Dec;30(12):780-792. doi: 10.1016/j.clon.2018.09.007. Epub 2018 Oct 11. Clin Oncol (R Coll Radiol). 2018. PMID: 30318343

8

Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.

Martens RM, Noij DP, Koopman T, Zwezerijnen B, Heymans M, de Jong MC, Hoekstra OS, Vergeer MR, de Bree R, Leemans CR, de Graaf P, Boellaard R, Castelijns JA. Martens RM, et al. Eur J Radiol. 2019 Apr;113:39-50. doi: 10.1016/j.ejrad.2019.01.031. Epub 2019 Feb 4. Eur J Radiol. 2019. PMID: 30927958

9

Comparison of diffusion-weighted MR imaging and ¹⁸F Fluorodeoxyglucose PET/CT in detection of residual or recurrent tumors and delineation of their local spread after (chemo) radiotherapy for head and neck squamous cell carcinoma.

Schroeder C, Lee JH, Tetzner U, Seidel S, Kim SY. Schroeder C, et al. Eur J Radiol. 2020 Sep;130:109157. doi: 10.1016/j.ejrad.2020.109157. Epub 2020 Jun 30. Eur J Radiol. 2020. PMID: 32652403 Free article.

10

Fractional change in apparent diffusion coefficient as an imaging biomarker for predicting treatment response in head and neck cancer treated with chemoradiotherapy.

Matoba M, Tuji H, Shimode Y, Toyoda I, Kuginuki Y, Miwa K, Tonami H. Matoba M, et al. AJNR Am J Neuroradiol. 2014 Feb;35(2):379-85. doi: 10.3174/ajnr.A3706. Epub 2013 Sep 12. AJNR Am J Neuroradiol. 2014. PMID: 24029391 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

104 results

Results by year